Publication | Closed Access

Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model

Breast OncologyOncologyMedicineFemale Rat ModelPathologyBone MarrowCyclophosphamide Damages BoneBreast CancerPharmacotherapyAnti-cancer AgentMetronomic ChemotherapyCancer TreatmentPharmacologyCancer ChemotherapyTumor MicroenvironmentChemotherapyCancer Research